Clinical Trials · NCT05959096
A Study of LY3437943 in Healthy Participants With a High Body Mass Index
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 85
- Start date
- Jul 2023
- Locations
- 1 site, United States
- Primary endpoint
- Part A: Pharmacokinetics (PK): Area Under the Plasma Concentration Versus Time Curve From Zero to Infinity (AUC[0-∞]) of LY3437943